Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Actual returns/credits applied related to prior-period by Year
Actual returns/credits applied related to prior-period sales ($M) ($M)
Moderna Actual returns/credits applied related to prior-period: $282M in FY2025, down 29.0% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-Q / 10-K Note 2 (Sales Returns Reserve Rollforward).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Actual returns/credits applied related to prior-period sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 282 | -29.0% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 397 | – | Form 10-K (filed 2025-02-21) ↗ |
Cite this data
StockData. (2026). Moderna Actual returns/credits applied related to prior-period ($M), annual FY2024–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/gtn-returns-paid-prior
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.